Evidence map›Paper›PMID 23612867›Full record

ArticleMycopathologia2013

Evaluation of Paracoccidioides brasiliensis infection by gp 43 intradermal test in rural settlements in Central-West Brazil.

Ana Paula da C Marques, Sandra Maria V L Oliveira, Grazielli R Rezende, Dayane A Melo, Sonia M Fernandes-Fitts, Elenir Rose J C Pontes, Maria da Glória Bonecini-Almeida, Zoilo P Camargo, Anamaria M M Paniago

Abstract readEvaluation Study
PubMed Publisher
In one paragraph

Article in Mycopathologia, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. New Trends in Paracoccidioidomycosis Epidemiology.Journal of fungi (Basel, Switzerland) · 2017
    Review
  9. Review
  10. EPIDEMIOLOGY OF PARACOCCIDIOIDOMYCOSIS.Revista do Instituto de Medicina Tropical de Sao Paulo · 2015
    Article
  11. Article
  12. Observational
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ana Paula da C MarquesUniversidade Federal do Mato Grosso do Sul, Cidade Universitária s/n, Campo Grande, 79070-900, Brazil.
Sandra Maria V L Oliveira
Grazielli R Rezende
Dayane A Melo
Sonia M Fernandes-Fitts
Elenir Rose J C Pontes
Maria da Glória Bonecini-Almeida
Zoilo P Camargo
Anamaria M M Paniago

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epidemiological studies of paracoccidioidomycosis have been based on surveys achieved with intradermal tests, and paracoccidioidin is the most common antigen used in most cases. The glycoprotein of 43-kDa (gp43) has been used in intradermal tests. It is the most antigenic component of Paracoccidioides brasiliensis, and it provides greater specificity to evaluate infection for this fungus. In this study, the prevalence of P. brasiliensis infection was estimated with intradermal tests involving gp43 for 695 people in rural Central-West Brazil. The infection rate was 45.8 % (95 % CI = 42.1-49.5), and the average age of those infected was 45.8 ± 18.2 years. The prevalence did not show gender-based differences but increased with age. The results demonstrate the importance of P. brasiliensis infection in rural settlements and the early exposure of children in the region to the fungus. Despite the high antigenicity and specificity of gp43, its usage must be standardized, so that epidemiological surveys will be comparable and more accurately reflect P. brasiliensis infection in endemic areas.

Indexed as

Antigens, FungalFungal ProteinsGlycoproteinsAdolescentAdultAgedAged, 80 and overBrazilChildChild, PreschoolFemaleHumansInfantIntradermal TestsMaleMiddle Aged43 kDa protein, ParacoccidioidesAntigens, FungalFungal ProteinsGlycoproteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.